These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 28467797

  • 1. Synergistic inhibition effect of TNIK inhibitor KY-05009 and receptor tyrosine kinase inhibitor dovitinib on IL-6-induced proliferation and Wnt signaling pathway in human multiple myeloma cells.
    Lee Y, Jung JI, Park KY, Kim SA, Kim J.
    Oncotarget; 2017 Jun 20; 8(25):41091-41101. PubMed ID: 28467797
    [Abstract] [Full Text] [Related]

  • 2. Traf2- and Nck-interacting kinase (TNIK) is involved in the anti-cancer mechanism of dovitinib in human multiple myeloma IM-9 cells.
    Chon HJ, Lee Y, Bae KJ, Byun BJ, Kim SA, Kim J.
    Amino Acids; 2016 Jul 20; 48(7):1591-9. PubMed ID: 26995282
    [Abstract] [Full Text] [Related]

  • 3. A novel aminothiazole KY-05009 with potential to inhibit Traf2- and Nck-interacting kinase (TNIK) attenuates TGF-β1-mediated epithelial-to-mesenchymal transition in human lung adenocarcinoma A549 cells.
    Kim J, Moon SH, Kim BT, Chae CH, Lee JY, Kim SH.
    PLoS One; 2014 Jul 20; 9(10):e110180. PubMed ID: 25337707
    [Abstract] [Full Text] [Related]

  • 4. TNIK inhibition abrogates colorectal cancer stemness.
    Masuda M, Uno Y, Ohbayashi N, Ohata H, Mimata A, Kukimoto-Niino M, Moriyama H, Kashimoto S, Inoue T, Goto N, Okamoto K, Shirouzu M, Sawa M, Yamada T.
    Nat Commun; 2016 Aug 26; 7():12586. PubMed ID: 27562646
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
    Park DS, Seo JH, Hong M, Choi SC.
    Biochem Biophys Res Commun; 2013 Jun 28; 436(2):338-43. PubMed ID: 23743195
    [Abstract] [Full Text] [Related]

  • 8. Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
    Shitashige M, Satow R, Jigami T, Aoki K, Honda K, Shibata T, Ono M, Hirohashi S, Yamada T.
    Cancer Res; 2010 Jun 15; 70(12):5024-33. PubMed ID: 20530691
    [Abstract] [Full Text] [Related]

  • 9. Direct conversion of osteosarcoma to adipocytes by targeting TNIK.
    Hirozane T, Masuda M, Sugano T, Sekita T, Goto N, Aoyama T, Sakagami T, Uno Y, Moriyama H, Sawa M, Asano N, Nakamura M, Matsumoto M, Nakayama R, Kondo T, Kawai A, Kobayashi E, Yamada T.
    JCI Insight; 2021 Feb 08; 6(3):. PubMed ID: 33400690
    [Abstract] [Full Text] [Related]

  • 10. TNIK influence the effects of antipsychotics on Wnt/β-catenin signaling pathway.
    Yuan R, Li Y, Fu Y, Ning A, Wang D, Zhang R, Yu S, Xu Q.
    Psychopharmacology (Berl); 2021 Nov 08; 238(11):3283-3292. PubMed ID: 34350475
    [Abstract] [Full Text] [Related]

  • 11. Discovery of 4-phenyl-2-phenylaminopyridine based TNIK inhibitors.
    Ho KK, Parnell KM, Yuan Y, Xu Y, Kultgen SG, Hamblin S, Hendrickson TF, Luo B, Foulks JM, McCullar MV, Kanner SB.
    Bioorg Med Chem Lett; 2013 Jan 15; 23(2):569-73. PubMed ID: 23232060
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
    Masuda M, Sawa M, Yamada T.
    Pharmacol Ther; 2015 Dec 15; 156():1-9. PubMed ID: 26542362
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Tam BY, Chiu K, Chung H, Bossard C, Nguyen JD, Creger E, Eastman BW, Mak CC, Ibanez M, Ghias A, Cahiwat J, Do L, Cho S, Nguyen J, Deshmukh V, Stewart J, Chen CW, Barroga C, Dellamary L, Kc SK, Phalen TJ, Hood J, Cha S, Yazici Y.
    Cancer Lett; 2020 Mar 31; 473():186-197. PubMed ID: 31560935
    [Abstract] [Full Text] [Related]

  • 17. Nuclear expression of phosphorylated TRAF2- and NCK-interacting kinase in hepatocellular carcinoma is associated with poor prognosis.
    Jin J, Jung HY, Wang Y, Xie J, Yeom YI, Jang JJ, Lee KB.
    Pathol Res Pract; 2014 Oct 31; 210(10):621-7. PubMed ID: 25160513
    [Abstract] [Full Text] [Related]

  • 18. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway.
    Liang Y, Li X, He X, Qiu X, Jin XL, Zhao XY, Xu RZ.
    Eur J Haematol; 2016 Oct 31; 97(4):371-8. PubMed ID: 26821882
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target.
    Lee RS, Zhang L, Berger A, Lawrence MG, Song J, Niranjan B, Davies RG, Lister NL, Sandhu SK, Rubin MA, Risbridger GP, Taylor RA, Rickman DS, Horvath LG, Daly RJ.
    Neoplasia; 2019 Apr 31; 21(4):389-400. PubMed ID: 30901730
    [Abstract] [Full Text] [Related]

  • 20. Anti-proliferative activity of CGK012 against multiple myeloma cells via Wnt/β-catenin signaling attenuation.
    Choi PJ, O Y, Her JH, Yun E, Song GY, Oh S.
    Leuk Res; 2017 Sep 31; 60():103-108. PubMed ID: 28772205
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.